Predict your next investment

Asset/Investment Management
sdiccapital.com

See what CB Insights has to offer

Investments

3

About SDIC Capital

SDIC Capital (国投资本) (SH: 600061) is an asset investment and management platform.

SDIC Capital Headquarter Location

Guotou Financial Tower, Building 2 Fu Cheng Men, Bei Da Street, Xicheng District

Beijing, Beijing,

China

010-83325163

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest SDIC Capital News

Marbridge Consulting - China Telecom, Mobile and Internet Research

Jun 4, 2018

NetEase Tech, 6/01/18 Beijing-based facial recognition solutions provider Shenxing Technology (Sensingtech) recently announced the completion of RMB 9-digit Series B funding led by Cash Capital with participation from SDIC Capital, and Keytone Ventures, as well as Series A investors Matrix Partners China and Fosun Kinzon Capital. Sensingtech is a computer vision company focused on public security. The company's big data integrated prevention and control platform is currently used by police forces in 17 provinces across China. The platform, built on technology to identify moving human faces, static human figures, and vehicles, provides predictions, warnings, and deployment plans for dynamic tracking analysis involved in police work including white list ID screening, criminal pursuit, case investigation, anti-terror operations, and closely monitoring persons of interest.

SDIC Capital Investments

3 Investments

SDIC Capital has made 3 investments. Their latest investment was in Porton Biologics as part of their Series A on April 4, 2021.

CBI Logo

SDIC Capital Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

4/19/2021

Series A

Porton Biologics

$61.45M

Yes

2

6/1/2018

Series B

Subscribe to see more

$99M

Subscribe to see more

10

8/5/2015

Series A

Subscribe to see more

$99M

Subscribe to see more

10

Date

4/19/2021

6/1/2018

8/5/2015

Round

Series A

Series B

Series A

Company

Porton Biologics

Subscribe to see more

Subscribe to see more

Amount

$61.45M

$99M

$99M

New?

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

2

10

10

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.